New York Times: Room for Debate: Experimental Drugs and the Ethics of Fighting Ebola
Multiple authors

“International medical teams this month could begin administering experimental Ebola drugs in West Africa, where the outbreak has killed more than 5,000 people. But is it ethical for the drugs to be given in randomized, controlled trials — considered the gold standard in methodology — since that would require some patients to take placebos? How can the development and testing of Ebola drugs and vaccines be accelerated while respecting ethical standards?” Multiple authors answer these questions and others in several opinion pieces published as part of this New York Times “Room for Debate” (12/1).